TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BOND

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BOND

ST13

US500000079211754

Classe

5, 9, 10, 42

Pedido

79211754

Registro

5577742

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

56

Atualização mais recente

16/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 10, 42

Data de depósito

04/04/2017

Data de registro

09/10/2018

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

18/03/2025

Última transação

16/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

708

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

82

Localização do titular

VIC, AU

Examinador

FIRST, VIVIAN M

Localização atual

Historical data usage

Titulares e representantes

Titulares

Leica Biosystems Melbourne Pty Ltd
Leica Biosystems Melbourne Pty Ltd

Representantes

Jessica G. McDonald Schwegman Lundberg & Woessner P.A.

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations, namely, pharmaceutical preparations for histological and cytological tissue processing applications and reagents for medical and medical diagnostic purposes; diagnostic preparations for medical use; reagents containing primary antibodies for medical use; chemical reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic reagents; clinical medical reagents; reagents for immuno-histochemistry detection and in situ-hybridisation detection for medical use; double, triple or multiple in situ hybridisation probes for application of multiple antibodies or probes in the same staining procedure to a tissue section during IHC staining for medical, research or veterinary purposes; epitope retrieval solutions for medical use; enzymes and enzyme preparations for medical and diagnostic purposes; diagnostic histological dye and stain solutions for medical use; dewaxing and wash buffers used with the aforementioned preparations for use in disease testing; diagnostic preparations for clinical or medical laboratory use

Classe 9

Diagnostic apparatus and instruments, not for medical purposes, including, apparatus for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use; apparatus for detection of tissue and/or cell based samples not for medical purposes; recorded and downloadable software for identifying and diagnosing cancer and other diseases and processing digital images; analysis apparatus for laboratory use for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining apparatus; measuring apparatus used to identify and/or diagnose cancer and other diseases, not for medical use; diagnostic testing apparatus incorporating chemical reagents not for medical use

Classe 10

Apparatus for detection of tissue and/or cell based samples, all for medical purposes; histopathology instruments; haematology instruments for clinical purposes, namely tissue staining instruments; diagnostic medical apparatus for performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining; in situ hybridisation probes; apparatus for medical use promoting and controlling reaction on microarrays or under slide covertiles used in conjunction with histopathology instruments, tissue staining instruments and diagnostic medical apparatus for performing immunohistochemistry and in situ hybridisation staining reactions and histological and pathological staining; in-vitro diagnostic testing apparatus incorporating chemical reagents for medical use; medical specimen collection slides for specimen collection in surgery

Classe 42

[ Medical research; installation and integration of computer software, including within existing hospital and laboratory infrastructure; maintenance, updating and upgrading of software; all the aforementioned for use in connection with medical analysis, diagnosis and research ]

Publicações

Histórico de despachos e eventos da marca no USPTO.

56 publicações encontradas

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

16/07/2026

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

16/06/2026

INPC

INVALIDATION PROCESSED

16/06/2026

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

18/11/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/10/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/10/2025

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

10/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/10/2025

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

18/03/2025

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

18/03/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/03/2025

ES75

TEAS SECTION 71 & 15 RECEIVED

08/10/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/10/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/02/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

18/01/2019

FIMP

FINAL DISPOSITION PROCESSED

18/01/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/01/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

09/10/2018

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

05/09/2018

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

24/07/2018

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

16/07/2018

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

13/07/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/06/2018

PUBO

PUBLISHED FOR OPPOSITION

26/06/2018

GPNX

NOTIFICATION PROCESSED BY IB

23/06/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/06/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/06/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/06/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

24/05/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/05/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

24/05/2018

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

24/05/2018

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

13/03/2018

GNSF

SUBSEQUENT FINAL EMAILED

13/03/2018

CFRC

SUBSEQUENT FINAL REFUSAL WRITTEN

13/03/2018

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/02/2018

GNFR

FINAL REFUSAL E-MAILED

07/02/2018

CNFR

FINAL REFUSAL WRITTEN

07/02/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/01/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/01/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/01/2018

ATRV

ATTORNEY REVIEW COMPLETED

30/11/2017

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

15/11/2017

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

27/10/2017

RFNT

REFUSAL PROCESSED BY IB

04/08/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

20/07/2017

RFRR

REFUSAL PROCESSED BY MPU

20/07/2017

MAFR

APPLICATION FILING RECEIPT MAILED

15/07/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

14/07/2017

CNRT

NON-FINAL ACTION WRITTEN

13/07/2017

DOCK

ASSIGNED TO EXAMINER

11/07/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/07/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/07/2017

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BOND ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.